Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
tafluprost (zioptan) (1 trial)
timolol (blocadren) (1 trial)
Glaucoma (Phase 3)
Glaucoma, Open-Angle (Phase 3)
Hypertension (Phase 3)
Ocular Hypertension (Phase 3)
Trials (1 total)
Trial APIs (2 total)